Hepatitis B Virus Reactivation and Mycobacterial Infections Associated With Ustekinumab: A Retrospective Study of an International Pharmacovigilance Database

Background: Reports were recently published on hepatitis B virus reactivation (HBVr), tuberculosis (TB), and atypical mycobacterial infection (AMI) in patients with ustekinumab treatment. However, the literature is limited to case reports and series. The study was aimed to investigate their relation...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jingjing, Geng, Xiaozhen, Zhang, Xin, Xiao, Yanfeng, Wang, Wenjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289361/
https://www.ncbi.nlm.nih.gov/pubmed/35860015
http://dx.doi.org/10.3389/fphar.2022.921084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289361/
https://www.ncbi.nlm.nih.gov/pubmed/35860015
http://dx.doi.org/10.3389/fphar.2022.921084

Ejemplares similares